| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Montréal International The economic promotion agency for Greater Montréal. We are the official economic development and promotion agency for the Montréal region. Whatever projects you may be planning—investment, setting up or expansion—we are there to welcome you and help you succeed. Our services are free and confidential. Profiting from both its European and North American heritage, Greater Montréal is unique among North American metropolises in that it actively leverages creativity as an economic, social and cultural driving force. It is also the only metropolis to offer businesses an ideal combination of factors that are key to success: competitive operating costs, direct access … | 50 | 19 | 24 | 189 |
 | Life Sciences BC “Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care Type: | 9 | 0 | 9 | 31 |
 | City of Fishers SMART. VIBRANT. ENTREPRENEURIAL. The City of Fishers is a suburb of Indianapolis, Indiana, located in Hamilton County and was named #1 Place to Live in the US by Money Magazine in 2017. Under the leadership of Mayor Scott Fadness, Fishers is known as a smart, vibrant, and entrepreneurial city through its neighborhood development, dedication to supporting high-growth companies, and innovative city processes. With a population of 91,832 (2017), Fishers is one of the fastest growing communities in Indiana and has received national accolades for entrepreneurship, livability, and safety. Key community assets include: - A vibrant Nickel Plate District complete with … Type: | 1 | 0 | 1 | 287 |
 | Biofourmis Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science … Type: | 30 | 3 | 27 | 411 |
 | Poolbeg Pharma plc Committed to the development and commercialisation of innovative medicines. Ticker: POLB Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to fund the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members … Type: | 5 | 0 | 5 | 16 |
 | Locus Biosciences, Inc. Locus Biosciences, Inc. is a biotechnology company that develops CRISPR-engineered precision antibacterial products. Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA. … Type: | 3 | 0 | 3 | 59 |
 |  Varda Space Industries Expanding the economic bounds of humankind. Low Earth orbit is open for business. Varda is accelerating the development of commercial space infrastructure, from in-orbit pharmaceutical processing to reliable and economical reentry capsules. Reusable rockets have lowered the cost of access to space and opened up a range of in-space activities. Now that access to space is cheap, it’s what we do there that counts. From new, life-saving pharmaceuticals to more powerful fiber optic cables, there is a world of products used on Earth today that can only be manufactured in space. Varda is accelerating innovation in the orbital economy and … Type: | 3 | 1 | 3 | 113 |
 | GLG The world's insight network GLG is the world’s largest insight network. We connect decision makers to the right experts so they can act with the confidence that comes from true clarity and have what it takes to get ahead. Our network of experts is the world’s largest source of first-hand expertise, and we recruit hundreds of new experts every day. We bring the power of insight to every great professional decision. Visit GLGinsights.com. For information regarding GLG’s practices with respect to personal information, please visit our privacy policy at https://glginsights.com/privacy-policy/ Professional Learning, Phone Consultations, Meetings, Roundtables, Site Visits, Strategic Projects, … Type: | 13 | 1 | 8 | 11,210 |
 | Medika Life Make informed choices about your health. Our MOBILIZETM platform highlights issues affecting global healthcare. Medika Life is an online health information platform dedicated to bringing scientifically-validated and actionable health information to the world. We focus on promoting the voices of healthcare practitioners from within the industry. Our MOBILIZETM Medicine platform addresses global and local issues affecting the delivery of basic healthcare to all communities. We are outspoken in terms of equality, both within the industry - from a professional perspective - and in the delivery and accessibility of services. Our articles, mostly written by colleagues across the medical spectrum, are … Type: | 4 | 0 | 2 | 7 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 36 | 13 | 25 | 186 |
 | Damon Runyon Cancer Research Foundation We fund high-risk, high-reward cancer research. We identify & enable young scientists who are brilliant, brave and bold. To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. To date, the Foundation has invested nearly $395 million in cancer research, supporting over 3,825 doctors and researchers. Its alumni include 13 Nobel Laureates and 86 members of the National Academy of Science (the science ‘Hall of Fame’). For more, visit … Type: | 11 | 1 | 9 | 33 |
 | CIC (Cambridge Innovation Center) Empowering Innovators Globally | Workspace, Labs, Event Space, Community CIC is the global leader in driving innovation at scale. Founded in 1999, CIC manages more than 1.5M square feet of workspace, laboratories, and event space across North America, Europe, and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on advancing innovation. Learn more at cic.com. office space, coworking, laboratories, innovation, startups, and real estate Type: | 32 | 4 | 20 | 347 |
 | CCI Midi-Pyrénées [Automatic translation follows] A network connected to its time, to businesses, to its missions, to its partners and to the natural elements AIR-MER-TERRE The CCI Midi-Pyrénées acts for the economic development of the region, alongside businesses. A place of consultation and coordination of the eight territorial chambers, the CCI Midi-Pyrénées carries out specific joint actions with them. The consular network has developed multiple services for businesses, from creation to transfer or transmission. It is also a contact of choice for students and workers looking for training. In 2015, the network of CCIs of Midi-Pyrénées supported 140 businesses in their energy … Type: | 103 | 33 | 68 | 111 |
 | Genialis The RNA Biomarker Company. Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker Type: | 14 | 0 | 13 | 42 |
 | Altoida, Inc. Pioneering digital #biomarkers of neurological disease using augmented reality and machine learning. Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine. Digital Health, … Type: | 10 | 0 | 9 | 44 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 29 | 10 | 23 | 84 |
 | Voxcan Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and … Type: | 6 | 1 | 5 | 18 |
 | Oregon Bioscience Association Advocate. Cultivate. Educate. Doing all things bio in the Pacific Northwest. Oregon Bioscience Association (@OregonBio) members are involved in cutting edge research and development of innovative health care, agricultural and environmental bio technologies. Our corporate members range from entrepreneurial start ups developing a first product to large multinationals. We also represent the state’s biotech research institutions, service providers to the industry and academic centers of learning. A unified voice for the Oregon bioscience community the Oregon Bio: * Represents the bioscience research to commercialization process * Helps to accelerate the growth of the biosciences industry in all parts of Oregon … Type: | 13 | 0 | 13 | 20 |
 | Amyris Make Good. No Compromise.® Amyris is a vertically integrated, synthetic biology company that creates sustainable, market-ready ingredients utilizing proprietary advanced precision fermentation technology and world-class platforms. Leveraging two decades of experience, Amyris collaborates with companies to co-create innovative ingredients at unprecedented speed and scale. This enables partners to deliver products with differentiated performance that meet sustainability and economic objectives. Its renewable and traceable ingredients are included in over 20,000 products from the world’s top brands, reaching more than 300 million consumers. For more information, please visit http://www.amyris.com. synthetic biology, specialty renewable chemicals, biotech, clean beauty, sweetener, CBD, natural ingredients, sustainability, … Type: | 12 | 0 | 13 | 1,037 |
 | Novaxia Your service provider in histology Since 1996, Novaxia is an independent laboratory offering customized services in histology. Whether you are a private or public research center, Novaxia accompanies you in your development projects. We work according to Good Laboratory Practices (G.L.P. Accreditation by the relevant French authority : ANSM). The range of services offered extend beyond classical histology, since today Novaxia offers services such as immunohistochemistry (IHC) and slide digitization. Our first priority is to put our knowledge and skills at your disposal. We want to understand your scientific question to ensure that we fully meet all of your expectations. … | 3 | 0 | 3 | 20 |
 | iLoF Using AI and Photonics to enable a new era of personalized, precision medicine. iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported … Type: | 20 | 0 | 18 | 38 |
 | Evaxion Biotech A/S AI-ImmunologyTM Powered Vaccines Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM … Type: | 2 | 0 | 2 | 58 |
 | Immunic Therapeutics Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/ Type: | 3 | 0 | 3 | 82 |
 | Kineta KA (Nasdaq) Developing next-generation immunotherapies for cancer patients! Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience | 4 | 0 | 3 | 29 |
 | Oncofactory 🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic … Type: | 5 | 1 | 4 | 8 |
 | Carthera Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical … Type: | 26 | 11 | 16 | 28 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … Type: | 24 | 12 | 14 | 37 |
 | The Center for Advancing Innovation Inc. CAI hosts a series of competitions to launch businesses from de-risked, near-term, and commercially viable inventions The Center for Advancing Innovation (CAI) is a global public-private partnership, non-profit focused on creating a virtuous circle of innovation and driving growth breakthroughs through novel, creative paradigms and models. CAI's mission is to accelerate and increase the volume of research commercialization in support of high growth business to ignite entrepreneurship, bolster the global economy, and maximize the commercial and knowledge-based potential of promising inventions. CAI's award-winning challenge-based accelerator, rigorous evidence-based due diligence, and capital-efficient lean management models serve to hyper-accelerate "gazelle" high-performing startups … Type: | 3 | 0 | 3 | 20 |
 | Stem Cell Network Powering regenerative medicine | Propulsons la médecine régénératrice The Stem Cell Network (SCN) is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine research. From the lab to the clinic, SCN’s goal is to power life-saving therapies and technologies through regenerative medicine research for the benefit of all. Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 270 world-class research groups, supporting over 250 research projects … Type: | 3 | 0 | 3 | 31 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 22 | 10 | 11 | 207 |
 | Flanders Investment & Trade (FIT) [Automatic translation follows] We facilitate foreign investment projects in Flanders and we give support to Flemish export companies Flanders Investment & Trade (FIT) is the partner to realize your international ambitions. At FIT, we strongly believe in the connecting power of international trade and foreign investments as a source of employment, a stimulus for knowledge sharing and a driving force for research and innovation. To further strengthen this dynamic, we get companies, organizations and professionals moving internationally. In this way, we stimulate them, and at the same time the engine of the Flemish economy. For this, we can call on … | 81 | 23 | 60 | 426 |
 | flanders.bio the cluster organisation empowering a life sciences driven network economy. flanders.bio is the cluster organisation empowering a life sciences driven network economy. We help our members to create value by organising networking and training activities, supporting internationalisation, providing services and building expertise. Biotechnology, life sciences, Sector organisation, MedTech, Agrotechnology, biotech, healthcare, Cluster, and agtech Type: | 7 | 4 | 2 | 25 |
 | MassBio Massachusetts is the State of Possible - the #1 life sciences cluster in the world - and we plan to keep it that way! MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy … Type: | 10 | 1 | 9 | 108 |
 | Microbiotica Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche … Type: | 6 | 1 | 1 | 50 |
 | mYXpression Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence … Type: | 19 | 4 | 18 | 9 |
 | Sense about Science Founded in 2002, Sense about Science is an independent charity promoting the public interest in sound science and evidence. We advocate for openness and honesty about research, working with decision-makers, researchers and community groups to raise the standard of evidence in public life. Our focus is on socially or scientifically difficult issues where evidence is neglected, conflicting or misunderstood. Type: | 2 | 0 | 1 | 21 |
 | Avantor We set science in motion to create a better world. Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, … Type: | 4 | 0 | 4 | 5,483 |
 | Downtown San Diego Partnership Promoting an economically prosperous and culturally vibrant urban center in Downtown San Diego. Who we are: The Downtown San Diego Partnership is a nonprofit organization that serves as the principal voice and driving force behind the economic prosperity and cultural vitality of Downtown San Diego through membership, advocacy and public services. It also serves as the managing organization for several special districts - including the Clean & Safe program - that provide essential public services in the 275 blocks of Downtown. The organization’s nearly 300 members, representing a variety of business sectors including real estate, technology, banking, law, defense, insurance, … Type: | 1 | 0 | 1 | 70 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 7 | 3 | 5 | 31 |
 | Life Science Cares Boston Harnessing the resources of the life science industry to end poverty in Greater Boston. Life Science Cares (LSC) is a collective effort of the life science industry connecting companies with nonprofits that improve the lives of people living in poverty in Greater Boston, Philadelphia, San Diego, New York & San Francisco. In Boston, LSC harnesses the sector’s human and financial resources from companies and supports a portfolio of 25 nonprofit organizations. LSC’s partner organizations work to address basic survival needs like food and shelter, improve education, and develop job skills that increase long term economic sustainability for the community’s most … Type: | 16 | 4 | 17 | 89 |
 | Evexta Bio Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in … Type: | 5 | 0 | 5 | 13 |
 | Future Fields We use fruit flies to help scientists change the world. Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a proud business member of 1% for the Planet, a … Type: | 6 | 0 | 5 | 40 |
 | IFPMA We represent the biopharmaceutical industry, partnering for global health progress and access to innovation. IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Biopharmaceuticals, Global Health Policy, Health Advocacy, Innovation, Medicines Quality, and Multistakholder Collaboration Type: | 38 | 12 | 30 | 73 |
 | Barinthus Biotherapeutics Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of … Type: | 9 | 2 | 5 | 128 |
 | TILT Biotherapeutics Ltd To make T-cells kill cancer, TILT is the answer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his … Type: | 4 | 0 | 4 | 25 |
 | Bengaluru Tech Summit Celebrating 27 years of Tech Summit in Bengaluru Bengaluru Tech Summit (BTS) organized by the Dept. of Electronics, IT, Bt and S&T, Govt. of Karnataka to be held from 19-21 Nov, 2024 at Bangalore Palace. Type: | 29 | 7 | 23 | 22 |
 | Innovative Health Initiative (IHI) We’re an EU public-private partnership funding health research & innovation. We also manage IMI projects. The Innovative Health Initiative (IHI) aims to translate health research and innovation into real benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research. Health research and care increasingly involve diverse sectors. By supporting projects that bring these sectors together, IHI will pave the way for a more integrated approach to health care, covering prevention, diagnosis, treatment, and disease management. IHI is a partnership between the European Union and European industry associations representing the pharmaceutical, … Type: | 24 | 11 | 7 | 79 |
 | Sofinnova Investments Innovation for Life Sofinnova Investments is a healthcare investment firm committed to funding innovative products that aspire to meaningfully impact the lives of patients. We invest in both private and public equity companies. Sofinnova actively partners with entrepreneurs across all stages of company formation, we are long-term investors with extensive scientific expertise, vast industry knowledge, and a track record of helping forge the path from drug development and navigating the regulatory process to company building and IPO or M&A. Founded in 1976, Sofinnova has a long legacy of building what we believe are great companies in both the U.S. and … Type: | 7 | 0 | 0 | 56 |
 | Invest Nova Scotia We support businesses small and large, new and new to Nova Scotia. 🇨🇦 Invest Nova Scotia is the business development agency of Nova Scotia, Canada. We work to promote economic growth and community economic development in the province, supporting businesses small and large, new and new to Nova Scotia. Please see the government of Nova Scotia terms of use: http://novascotia.ca/terms/ Nova Scotia, Canada, Halifax, Business Development, Investment Opportunities, Business Support, Business Resources, Trade Development, Export Development, Business Financing, Business Consulting, Foreign Direct Investment, Venture Capital, Incubation, Technology Start-ups, and Entrepreneurship Type: | 15 | 2 | 12 | 225 |
 | FreeMind Group Helping life science companies win non-dilutive funds from US federal agencies & private foundations to fund their R&D We're celebrating our 25th anniversary! Established in 1999, the FreeMind Group mission is to assist life science organizations secure non-dilutive funding from US federal agencies and private foundations to fund R&D. For each project in our client’s pipeline, we provide a robust, long-term, multi-submission granting strategy. Our team is well versed in the interests, goals, and available funding opportunities of each funding source. Combining their extraordinary scientific understandings, innovative business and financial expertise, and writing and presentation skills, our team works with … Type: | 5 | 0 | 5 | 84 |
 | Nuclera Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology … Type: | 7 | 1 | 4 | 128 |
 | Global Genes Leading patient advocacy organization working to eliminate the challenges of rare disease. #CareAboutRARE #RareDisease Empowering the Next Generation Rare Disease Advocate. Global Genes and RARE-X officially merged into one organization December 2022 under the name Global Genes. Both organizations have been working toward the goal of empowering the next generation advocate both through their individual initiatives and their strategic partnership announced in 2021. In fact, RARE-X was born out of Global Genes after discussions with advocacy leaders, board members, partners, patients, and care partners, addressing a significant gap in access to tools, technology, and infrastructure. We're Hiring! Check out our … Type: | 4 | 0 | 4 | 56 |
 | Organon Mid-Europe (France, Belgium, Luxemburg, Switzerland) France, Belgium, Luxemburg, Switzerland. One Team for better & healthier every day for every woman. Organon, here for her health We are a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established brands across a wide array of conditions and diseases. For more information, visit www.organon.fr or follow us on https://twitter.com/OrganonFrance Type: | 10 | 3 | 8 | 111 |
 | EnteroBiotix Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome. Type: | 1 | 0 | 1 | 58 |
 | Sepsis Alliance Save lives and reduce suffering by improving sepsis awareness and care. Sepsis Alliance Saves lives by raising awareness of sepsis as a medical emergency and support those impacted by this devastating disease. Some Facts: 1. Sepsis is the #3 cause of death in the U.S. 2. Sepsis is the #1 cost for U.S. hospitals 3. Sepsis is the leading cause of death in U.S. hospitals 4. 80% of sepsis cases arrive at the hospital 5. Sepsis is preventable and treatable in most cases About Sepsis Alliance: Sepsis Alliance is the leading sepsis organization in the U.S., working in all 50 … Type: | 5 | 1 | 4 | 52 |
 | Kelonia Therapeutics Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines. Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal … Type: | 2 | 1 | 1 | 60 |
 | Emily Whitehead Foundation Activate The Cure for Childhood Cancer Activate the Cure for Childhood Cancer. The Emily Whitehead Foundation’s mission is to raise awareness and funding for innovative childhood cancer treatments, such as immunotherapy, that will improve survival rates and quality of life. About Emily Whitehead: Emily was the first pediatric patient enrolled in a highly experimental phase I clinical trial called CAR-T cell therapy at Children’s Hospital of Philadelphia (CHOP) and became the first child in the world to have her immune system trained to fight cancer. The experimental T-cell therapy worked and Emily is now approaching ten years cancer free. Childhood … Type: | 4 | 0 | 4 | 18 |
 | California Life Sciences (CLS) California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization. California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this … Type: | 9 | 0 | 9 | 11 |
 | Big4Bio Your daily digest of life science developments in the top bioclusters in the world. The life sciences sector is witnessing unprecedented levels of innovation and investment, while the health care industry as a whole is in the midst of a sea change. If you aren’t a full-time analyst, how can you keep up and find the key information you need to make the right decisions for your business? That’s where we come in. Big4Bio is the premier life sciences aggregator of financial, clinical, and business news. Our free, daily emails give you easy-to-scan headlines on key developments and links to … Type: | 2 | 0 | 1 | 9 |
 | AusBiotech Australia's Biotechnology Organisation AusBiotech is Australia's Biotechnology Industry Organisation, which represents over 3,000 members working in life sciences, including therapeutics, medical technology (devices and diagnostics), digital health, food technology and agricultural sectors. AusBiotech is dedicated to the development, growth and prosperity of the Australian Biotechnology Industry, by providing initiatives to drive sustainability and growth, outreach and access to markets, and representation and support for members nationally and around the world. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialisation of Australian bioscience in the national and international marketplaces. The structure is … Type: | 5 | 2 | 3 | 59 |
 | McDonnell Boehnen Hulbert & Berghoff LLP Intellectual Property Law: Up to Speed. Down to Earth. At MBHB, the legal and scientific credentials of our professionals are first rate. Period. We speak the languages of law and science—and of the people we serve. One hundred percent of MBHB’s attorneys and technical advisors hold science or engineering degrees. Of these, nearly 50% of our attorneys and technical advisors hold Ph.D.s or other advanced degrees. We’re “up to speed” on the science and technology involved in IP law. But we’re also very “down to earth” in the way we choose to run our firm. As an intellectual property law … | 1 | 0 | 1 | 126 |
 | Prince Edward Island BioAlliance Coordinating the cluster of organizations dedicated to increasing the economic impact of the bioscience sector in PEI. The Prince Edward Island BioAlliance is the private sector-led not-for-profit organization that is responsible for developing and coordinating the strategy for the growth of the Prince Edward Island Bioscience Cluster. Since 2005, the BioAlliance has facilitated the work of businesses, academic and research institutions, and federal and provincial government agencies in establishing the bioscience sector as a key pillar in the economic foundation of the province and Atlantic Canada. Building from plans developed since 2005, the collaborative model of the BioAlliance has enabled … Type: | 3 | 0 | 3 | 5 |
 | Emergence Atlantic Canada's Bioscience Business Incubator Emergence is a business incubator dedicated to assisting start-ups and growth stage bioscience companies in efficiently bringing their products and services to market. Emergence clients benefit from access to business, technical, scientific and regulatory support services customized to meet their individual needs. This includes one-on-one and team-based mentorship; third-party consulting services; market research; legal, IP, insurance, tax and financial expertise from a network of professional service provider partners; and support accessing international networks and public and private funding and investment opportunities. Emergence serves high-potential companies wherever they are located in Canada, while also providing a … Type: | 1 | 0 | 1 | 3 |
 | DIVA Expertise [Automatic translation follows] DEEP INNOVATION on adipose tissue. Research partner from the cell to Humans D.I.V.A. Expertise is a consulting, strategy and development company in scientific research in the fields of Health, Nutrition, Cosmetics and Aesthetics. Its objectives are to support manufacturers in the structuring, organization and development of their research in order to optimize its costs, deadlines and results. Personalized support from our experts boosts the R&D process of a product by promoting Creativity, Innovation and Collaboration. Its core expertise is targeted on the biology of fatty tissue called adipose, recognized as an endocrine organ with a fundamental and … Type: | 6 | 1 | 4 | 9 |
 | AbilityPharma Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space. AbilityPharma's is currently conducting, with ABTL0812, the most advanced asset, an international multi-center, double-blind, placebo-controlled phase 2b clinical trial in patients with metastatic pancreatic cancer to investigate ABTL0812 as first-lin therapy in combination with FOLFIRINOX chemotherapy. The study includes reference centers in Spain, France, United States and Israel. ABTL0812 has finished with very positive results a phase 2a clinical trial as first-line therapy in endometrial cancer and in squamous NSCLC in combination with paclitaxel and carboplatin. The study included … Type: | 2 | 0 | 2 | 22 |
 | Equilar The Trusted Source for Executive Intelligence Equilar is the leading provider of executive intelligence solutions. The company’s expertise in relationship intelligence drives state-of-the-art business development and CRM applications, board and executive recruitment, and compensation and governance strategies. Equilar integrates its extensive database of executive profiles with natural language processing and machine learning AI to enable real-time relationship analytics and targeted outreach for its global clients. Equilar's commitment to excellence has made it the go-to solution for over 1,000 companies, including 75% of the Fortune 500, top PE/VC firms, and leading professional services entities. Learn more at www.equilar.com. Human Resources, Shareholder … Type: | 19 | 0 | 19 | 137 |
 | Sunstein LLP Intellectual property law is continuously evolving. Sunstein is at the forefront. Sunstein LLP is a boutique Intellectual Property firm with a 40-year history of success and expertise in all areas of IP law including litigation, patent and trademark prosecution, intellectual property portfolio development and business transactions. IP law is rapidly evolving and Sunstein has been at the forefront of these changes. Law firm, IP firm, Intellectual Property, Patent, Copyright, and Trademark | 4 | 0 | 4 | 76 |
 | KEZAD Group Khalifa Economic Zones Abu Dhabi KEZAD Group (Khalifa Economic Zones Abu Dhabi) is the UAE's largest operator of fully-integrated economic zones and value added business services, staff accommodation and industrial real estate solutions. Committed to creating competitive business ecosystems that encourage unprecedented growth, KEZAD Group is a key enabler of Abu Dhabi’s vision for the diversification of its economy. The Group helps build an open, agile and integrated business environment that attracts foreign and local investments to Abu Dhabi by offering outstanding market access, lower operating costs, and ease of doing business both in the region and globally. KEZAD Group's … Type: | 2 | 1 | 1 | 136 |
 | Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-JPEO-CBRND JPEO-CBRND: Providing the warfighter with the best CBRN defense technology, equipment and medical countermeasures Welcome to the official Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) LinkedIn page. Our mission is to provide the warfighter with the best CBRN defense technology, equipment and medical countermeasures at the right cost, at the right time and at the right place. For more information, visit https://jpeocbrnd.osd.mil MISSION Provide integrated layered chemical, biological, radiological, and nuclear defense capabilities to the Joint Force across Combined Joint All-Domain Operations VISION A resilient Joint Force enabled to fight and win unencumbered by a … Type: | 4 | 0 | 3 | 179 |
 | Ultragenyx Going Beyond Every Day Leading with purpose. Every day. “Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.” Emil D. Kakkis, M.D., Ph.D. Chief Executive Officer and President We have an inclusive culture of value and … Type: | 3 | 0 | 3 | 1,488 |
 | Syngulon Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. … Type: | 5 | 2 | 2 | 10 |
 | AMR Industry Alliance The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify … Type: | 12 | 2 | 6 | 11 |
 |  The Bayh-Dole Coalition Research and scientific organizations committed to protecting the Bayh-Dole Act and educating policymakers about it. The Bayh-Dole Coalition is a diverse group of research and scientific organizations, as well as those directly involved in commercializing new products, committed to protecting the Bayh-Dole Act and educating policymakers about the positive impacts of the law. Type: | 1 | 1 | 0 | 2 |
 | Aequor A Group of Companies - Global IT/Staffing, Healthcare/Clinical/Therapy, Education/Finance, S/W Solutions & Consulting. Since 1998, Aequor has provided exceptional workforce staffing services in multiple industries. Specializing in healthcare, we place nurses, therapists, allied professionals, physicians and medical technicians, as well as staff in the life sciences, technologies and schools. We believe in making a positive impact in the lives of those we serve by inspiring people and empowering growth both personally and professionally, which makes us better as individuals and as a company. We teach our team members to nurture positive and supportive relationships with our clients and candidates by … Type: | 1 | 1 | 0 | 439 |
 | Solve ME/CFS Initiative Working to make ME/CFS widely understood, diagnosable, and treatable. #SolveME #MECFS Donate: solvecfs.org/donate/ Solve M.E. is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other infection-associated chronic conditions and illnesses (IACCIs). Our work with the scientific, medical, and pharmaceutical communities, advocacy with government agencies, and alliances with patient groups around the world are laying the foundation for breakthroughs that can improve the lives of millions who suffer from various “long haul” diseases. Follow our page to stay up to date on the latest … Type: | 1 | 1 | 0 | 31 |
 | Delaware Prosperity Partnership The Delaware Prosperity Partnership (DPP) attracts, grows & retains businesses and strengthens the innovation ecosystem. The Delaware Prosperity Partnership (DPP) team is committed to supporting companies who want to grow or locate their company in Delaware. We also support building a stronger entrepreneurial and innovation ecosystem and private employers in identifying, recruiting and developing talent in Delaware. What We Do: The DPP team makes it easy for you to do business in Delaware. Whether you’re a site selector or advisor, commercial real estate developer, or C-Suite executive decision maker responsible for reviewing optimal sites to establish, expand, or relocate your … Type: | 8 | 2 | 6 | 19 |
 | Virginia Bio connecting the life sciences community The Virginia Biotechnology Association (Virginia Bio), formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. More than 200 member organizations have joined forces to make Virginia Bio an effective advocate for the biopharmaceutical and device industries before federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Industry Organization (BIO), in Washington, D.C. Professional service firms, research labs and all manner of bioscience companies are welcome to participate. To join Virginia Bio, please visit us at www.vabio.org, on X … Type: | 4 | 0 | 3 | 15 |
 | Delaware Business Times Delaware's Must-Read Source for Business News. Using multiple platforms, Delaware Business Times provides timely, informative content to tens of thousands of decision-makers across the First State. From breaking news coverage and in-depth reporting to hosting networking and premier recognition events, Delaware Business Times has been connecting its readers with marketers for over a decade. Today Media is a multi-platform communications company providing content that attracts hundreds of thousands of loyal consumers each day and offers marketers advertising solutions in print, online, and in person. In addition to Delaware Business Times, Today Media publishes Delaware Today, Main Line Today, Westchester Magazine, … Type: | 2 | 0 | 2 | 6 |
 | Astellas Gene Therapies Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience. gene therapy and biotechnology Type: | 3 | 0 | 2 | 407 |
 | Vivani Vivani Medical is a pre-clinical-stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortalTM platform, Vivani’s portfolio of tiny, sub-dermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is developing two miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-115 (exenatide) and NPM-139 (semaglutide). In addition, the company is developing NPM-119, a lower dose exenatide implant for the treatment of type 2 diabetes. Type: | 2 | 1 | 1 | 21 |
 | LifeScience WorldWide LifeScience & Biotech Worldwide Biotech Developments Type: | 11 | 0 | 11 | 1 |
 | Space Tango Unearth Answers in Microgravity for Humanity Space Tango is an industry leader in automated systems in the pursuit of health and technology manufacturing in space. Since 2017 through a NASA Space Act Agreement, Space Tango provides facilities to support iterative R&D and manufacturing in space. Through an integrated and intuitive approach, Space Tango works alongside its diverse partner base to embrace pathways to on-orbit production yielding valuable and transformational solutions for humanity. Space Tango believes the microgravity environment is a new frontier for discovery and innovation. We are focused on creating a new global market 250 miles up in low … Type: | 2 | 2 | 0 | 31 |
 | Kezar Life Sciences Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be … Type: | 1 | 1 | 0 | 71 |
 | Wallonia.be/fr [Automatic translation follows] Feel inspired Official portal of Wallonia internationally Wallonia.be Wallonia: An open region, a land of exchanges Wallonia is a region naturally open to the world, where languages and cultures dialogue. An export vocation. An extraordinary sense of welcome. A land of industrial tradition, Wallonia has forged its identity through immigration. It has a young, internationally mobile population. The colleges and universities, present in world rankings, are distinguished by a very high proportion of foreign students. Sense of sharing, Accessibility, Technological know-how, and Quality of life Type: | 14 | 0 | 14 | 31 |
 | Business France (Invest in France) Business France and its partners: promoting and supporting foreign investment in France Creators of business opportunities, throughout the world 🌍 International development is key to the development of your business. What if a meeting with Business France was what you needed to give your projects a new dimension? Our three flagship professions all have one thing in common: boosting you on the global stage! To fast-track exports, we make the daily lives of entrepreneurs easier by providing them with the power of our network. To generate investments and employment in France, we promote the economic attractiveness of our … Type: | 144 | 12 | 141 | 16 |
 | Ginkgo Bioworks, Inc. Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our … Type: | 13 | 9 | 1 | 1,283 |
 | NewYorkBIO NewYorkBIO supports the development and growth of New York State’s life science industry. NewYorkBIO supports the development and growth of New York State’s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. Type: | 23 | 1 | 24 | 14 |
 | Cytovance Biologics We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner. Welcome to Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for clinical … Type: | 2 | 0 | 0 | 222 |
 | Rabin Martin Together, we can make a lasting impact on global health – and your business. We’re Rabin Martin, a team of global health impact consultants. Driving better outcomes, access and equity – from strategy to execution. We design, develop and deliver effective solutions to unlock new markets and opportunities – creating creative ways for more people to access our client's medicines and vaccines, and generating support among key stakeholders. In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth. To do this, we bring together … Type: | 19 | 1 | 19 | 46 |
 | Pennsylvania Department of Community & Economic Development Satisfaction comes through both work and quality of life – and Pennsylvania delivers it all. The Department of Community and Economic Development’s mission is to encourage the shared prosperity of all Pennsylvanians by supporting good stewardship and sustainable development initiatives across our commonwealth. With a keen eye toward diversity and inclusiveness, we act as advisors and advocates, providing strategic technical assistance, training, and financial resources to help our communities and industries flourish. community and economic development, expansion and relocation, small business development centers, trade and investment, expertise, network of domestic and international partners, business resources and services, business assistance, financial … | 24 | 3 | 21 | 480 |
 | Poseida Therapeutics, Inc. The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies as well as in-house … Type: | 3 | 0 | 3 | 332 |
 | MindMed MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the … Type: | 4 | 0 | 3 | 97 |
 | Corn Refiners Association Representing the corn wet milling industry and safe and affordable corn products since 1913. The Corn Refiners Association (CRA) is the national trade association representing the corn refining industry of the United States. CRA and its predecessors have served this important segment of American agribusiness since 1913. CRA advocates for science-based public policy and economically-sound decisions at the state, federal, and global levels. It approaches every new challenge with its members and their customers in mind, working to foster technological innovation, expand commercial opportunities, advance free trade, build the bioeconomy, and feed a hungry world. ABOUT THE INDUSTRY: Corn refiners … Type: | 1 | 0 | 0 | 26 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … Type: | 6 | 0 | 6 | 52 |
 | Daré Bioscience, Inc. Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt … Type: | 6 | 0 | 4 | 26 |
 | EveryLife Foundation for Rare Diseases The EveryLife Foundation for Rare Diseases educates, supports and amplifies the voice of rare disease patient advocates. We empower the rare disease patient community to advocate for impactful, science-driven legislation and policy that advances the equitable development of and access to lifesaving diagnoses, treatments, and cures. Advocacy, Patient Engagment, Rare Diseases, and Public Policy Type: | 14 | 0 | 13 | 57 |
 | LanzaTech Recycling carbon with biology Our way of life is built on carbon, from our fuel sources to the materials in our consumer products, but we need a more sustainable way to source it to protect the future of our planet. LanzaTech Global, Inc. is the carbon recycling company transforming waste carbon into sustainable raw materials for everyday products. Using its biorecycling technology, LanzaTech captures carbon-rich gases generated by energy-intensive industries at the source, preventing them from being emitted into the air. LanzaTech then gives that captured carbon a new life as a sustainable replacement for virgin fossil carbon in everything … Type: | 23 | 6 | 10 | 409 |
 | Illinois Biotechnology Innovation Organization (iBIO) To promote, connect and engage the life sciences community The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association of more than 500 members comprised of life sciences companies, universities, academic institutions, service providers and others dedicated to making Illinois and the surrounding Midwest one of the world’s top life sciences centers. We drive industry growth by creating a forum for the life sciences community to come together, educating the public and policy makers, influencing public policy and advancing the economic interests of the community. iBIO’s members range from small startups to global corporations. They work in the … Type: | 8 | 0 | 7 | 7 |
 | LaVoieHealthScience Team of specialized thinkers and executors in health and science innovation. Global Alliance with Omnicom PR Group LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target stakeholders to create behavioral change. Our focus is on building value for health science innovations. Through our alliance with Omnicom Public Relations Group, we bring high-touch service with the global scale of 2,000 health expert consults across 100 countries. We help our clients create awareness, gain recognition and optimal value for their initiatives, technologies, products and businesses. Our expert team of investor relations and public relations … Type: | 3 | 0 | 3 | 13 |
 | Hesperos Inc. The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the … Type: | 2 | 0 | 2 | 64 |
SMB